Isolated CNS Blast Crisis of CML in A Patient on Dasatinib TherapyRehab Al-blooshi1, Dimitrios Vergidis2 and Jeffrey H Lipton3*
- *Corresponding Author:
- Jeffrey Lipton
PhD, MD, Department of Medical Oncology and Hematology
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
E-mail: [email protected]
Received date: May 07, 2016; Accepted date: June 09, 2016; Published date: June 13, 2016
Citation: Al-blooshi R, Vergidis D, Lipton JH (2016) Isolated CNS Blast Crisis of CML in A Patient on Dasatinib Therapy. J Leuk 4:212. doi:10.4172/2329-6917.1000212
Copyright: © 2016 Al-blooshi R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
We report a case of a young male with chronic phase CML who despite achieving an excellent response to dasatinib therapy, developed isolated CNS blast crisis even though this tyrosine kinase inhibitor is the only one reported to cross the blood brain barrier.